(Q84433512)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Cintia M dos Santos Silva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Flavia R P Barbosa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Giovanna A B Lima

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Leila Warszawski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Rosita Fontes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Romeu C Domingues

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Mõnica R Gadelha

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

17 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

800-805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

Cause-specific excess deaths associated with underweight, overweight, and obesity

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Classical endocrine diseases causing obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Hyperprolactinaemia as a reversible cause of weight gain in male patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

The effects of hyperprolactinemia on bone and fat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Decreased sensitivity to insulin in women with microprolactinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Hyperprolactinemia stimulates food intake in the female rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Protective effects of adenosine in the perfused rat heart: changes in metabolism and intracellular ion homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Reversible weight gain and prolactin levels--long-term follow-up in childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

The prolactin-deficient mouse has an unaltered metabolic phenotype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Brain dopamine and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Body fat in nonobese women with prolactinoma treated with dopamine agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

The metabolic syndrome--a new worldwide definition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Diagnosing insulin resistance in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Prevalence of metabolic syndrome in population-based study, Vitória, ES-Brazil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

[Laboratorial evaluation and diagnosis of insulin resistance].

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Bromocriptine--unique formulation of a dopamine agonist for the treatment of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

Prolactinoma and body weight: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

7 January 2021

Prolactin stimulates leptin secretion by rat white adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

7 January 2021

Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

7 January 2021

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.150

7 January 2021

Identifiers

DOI

10.1038/OBY.2010.150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20559294%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference